GenScript Launches Global Philanthropy Platform: The GenTeer Program
PISCATAWAY, N.J., Aug. 21, 2024 /PRNewswire/ -- On August 19, GenScript Biotech Corporation (referred to as GenScript) officially launched the "GenTeer (GenScript Volunteer) Program," an innovative global philanthropy platform. This initiative marks a significant step for GenScript, transitioning from organizing isolated charity events to building a global volunteer service ecosystem. The platform is designed to empower every GenScript employee to...
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
New Veeva Pulse findings show congresses and early-career experts have the strongest influence on patient outcomes SINGAPORE, Aug. 21, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing...
Coway Launches First-Ever Customized Filter Line for Top-Selling Airmega Air Purifier Models
Intense Smoke, Pet and Allergen Filters, Designed for Coway Airmega Mighty AP-1512HH and Airmega 200M, Eliminate Up to 99% of Harmful Airborne Particles LOS ANGELES, Aug. 21, 2024 /PRNewswire/ -- Coway, a leading wellness tech company, today launched its first-ever customized Intense Smoke, Pet, and Allergen filters in the U.S. for its most...
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth
Revenue surged by 67.6% YoY to RMB 1,665 million Gross profit surged by 133.4% to RMB 535 million, with a gross profit margin of 32.1%, a 9.0 percentage points increase compared to 1H 2023. Net profit increased by 175.5% to RMB 488 million, with a net profit margin of 29.3%, a 11.5 percentage points increase compared to 1H...
Kelun-Biotech’s TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC
CHENGDU, China, Aug. 20, 2024 /PRNewswire/ -- On August 20, the new drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal OptiTROP-Lung03 study has been accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech",...
Infinitus Highlights Modernizing Traditional Prescriptions at ICMCM
GUANGZHOU, China, Aug. 20, 2024 /PRNewswire/ -- Recently, the highly-anticipated 23rd International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) took place in Hong Kong, bringing together global experts, top researchers and industry leaders in traditional medicine. The gathering fostered robust online and offline interactions, centering its discourse on the theme of "Industry-University-Research Collaboration and...
Bone Index Announces Successful Financing Round and Strategic Partnership with Lynx Financial
KUOPIO, Finland, Aug. 20, 2024 /PRNewswire/ -- Bone Index Finland Ltd, a pioneering company in medical technology, proudly announces the completion of its latest financing round and a strategic partnership with Lynx Financial (HK) Limited. This partnership aims to enhance Bone Index's distribution and service capabilities in North America and Asia Pacific....
Pink Lifestyle Partners with PJUR to Enhance Wellness
SINGAPORE, Aug. 20, 2024 /PRNewswire/ -- Pink Lifestyle is pleased to announce its collaboration with PJUR, a globally renowned brand. Supported by Blitzwerks, its parent company, this partnership marks a milestone in expanding the availability of high-quality wellness products in Singapore. Pink Lifestyle Physical Store Advocating for Enhanced Wellness with Strategic Collaboration As consumers become increasingly conscious...
The Infinitus Global R&D Center Achieves CNAS Accreditation
GUANGZHOU, China, Aug. 19, 2024 /PRNewswire/ -- The Infinitus Global R&D Center has successfully passed an on-site evaluation by the expert panel from the China National Accreditation Service for Conformity Assessment (CNAS), marking the third consecutive recognition for Infinitus following the accreditations of the Xinhui and Yingkou Testing Centers. The Infinitus Global R&D Center...
#PlumeStrong 2024 Campaigns to Benefit Street Child and Ron Brown Scholar Program
PALO ALTO, Calif., Aug. 19, 2024 /PRNewswire/ -- Now in its fourth year, #PlumeStrong is proud to announce two significant fundraising events: the #PlumeStrong Cycling Challenge (#PSCC24) and a Gala Philanthropic Dinner. Plume and its employees, with the help of generous corporate sponsors and individuals, are seeking to raise €1,000,000 to...
